https://tie2-signaling.com/ind....ex.php/efficacy-rega
V.Subcutaneous (SC) delivery of biotherapeutics is well established as a route of administration across many healing areas and contains demonstrated an ability to work and well-tolerated. It could provide a few benefits over intravenous administration. This notwithstanding, there stay vital development issues and understanding gaps in SC drug distribution. To articulate and address these problems, the SC Drug Delivery and Development Consortium had been convened in 2018 as a
Like
Comment
Share
